Citations

Clear

13603 citation(s) found for "_, _".

State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology
Svennberg, Emma , Han, Janet K. , Caiani, Enrico G. , Engelhardt, Sandy , Friedman, Paul A. , Garcia, Rodrigue , Ghanbari, Hamid , Hindricks, Gerhard , Man, Sharon , Hansen, Jacob Tfelt, Barker, Joseph, Casado-Arroyo, Ruben, Chatterjee, Neal A, Conte, Giulio, Diederichsen, Søren Zöga, Linz, Dominik, Mahtani, Arun Umesh, Zorzi, Alessandro, Tfelt‐Hansen, Jacob , Diederichsen, Søren Zöga , Ernst, Sabine , Friedman, Paul A , Garcia, Rodrigue , Hindricks, Gerhard , Man, Sharon H , Millet, José , Narayan, Sanjiv M , Ng, G. André , Noseworthy, Peter A , Tjong, Fleur V Y , Ramírez, Julia , Singh, Jagmeet P , Trayanova, Natalia A , Duncker, David , Tfelt-Hansen, Jacob , Diederichsen, Søren Z , Ernst, Sabine , Narayan, Sanjiv M. , Noseworthy, Peter A. , Ramírez, Julia , Trayanova, Natalia A. , Duncker, David , Barker, Joseph, Casado-Arroyo, Ruben, Chatterjee, Neal A, Conte, Giulio, Linz, Dominik, Mahtani, Arun Umesh, Zorzi, Alessandro

Mayo Clinic

Europace | March 31, 2025 | Volume: 27 | Issue: 5 | Pages: No page available

10.1093/europace/euaf071 | PMID 40163651 Get It

Abstract Aims Artificial intelligence (AI) has the potential to transform cardiac electrophysiology (EP), particularly in arrhythmia detection, procedural optimization, and patient outcome prediction. However, a standardized approach to reporting and understanding AI-related research in EP is lacking. This scientific statement aims to develop and apply a checklist for AI-related research reporting in EP to enhance transparency, reproducibility, and understandability in the field. Methods and results An AI checklist specific to EP was developed with expert input from the writing group and voted on using a modified Delphi process, leading to the development of a 29-item checklist. The checklist was subsequently applied to assess reporting practices to identify areas where improvements could be made and provide an overview of the state of the art in AI-related EP research in three domains from May 2021 until May 2024: atrial fibrillation (AF) management, sudden cardiac death (SCD), and EP lab applications. The EHRA AI checklist was applied to 31 studies in AF management, 18 studies in SCD, and 6 studies in EP lab applications. Results differed between the different domains, but in no domain reporting of a specific item exceeded 55% of included papers. Key areas such as trial registration, participant details, data handling, and training performance were underreported (<20%). The checklist application highlighted areas where reporting practices could be improved to promote clearer, more comprehensive AI research in EP. Conclusion The EHRA AI checklist provides a structured framework for reporting AI research in EP. Its use can improve understanding but also enhance the reproducibility and transparency of AI studies, fostering more robust and reliable integration of AI into clinical EP practice.
FP5.4 Labral re-fixation versus debridement for symptomatic femoroacetabular impingement (FAI): A Matched Analysis at Mean 10-year outcomes in a Prospective, Multi-Center Cohort
Bedi, Asheesh , Nepple, Jeffrey J. , Thapa, Susan , Millis, Michael B. , Kim, Young‐Jo , Group, ANCHOR Study, Clohisy, John C., Beaulé, Paul E. , Sierra, Rafael J. , Group, ANCHOR Study, Clohisy, John C.

Mayo Clinic

Journal of Hip Preservation Surgery | March 31, 2025 | Volume: 12 | Issue: Supplement_1 | Pages: i14-i14

10.1093/jhps/hnaf011.042 Get It

Abstract Introduction: Labral injury at the time of open and arthroscopic hip preservation surgery for symptomatic femoroacetabular impingement (FAI) is managed with debridement versus refixation by the treating surgeon based on tear pattern, tissue quality, and hip morphology. While refixation has been favored based on mid-term outcomes in some series, differences in the long-term patient reported outcomes (PROMS) have not been defined in well-designed and matched prospective series. Methods: This study consisted of a prospective, multi-center cohort that underwent primary surgical treatment for symptomatic FAI. Patients were included if they underwent corrective osteoplasty and a labral refixation or a labral debridement procedure. Using a ratio of 1:1, hips with labral refixation and labral debridement were matched by age, sex, and surgical approach. Postoperative assessments were conducted at a minimum 8 years after surgery using PROMS and assessment of reoperations. Results: A total of 237 hips (n=188 labral refixation, n=49 labral debridement) met the inclusion criteria for the current study. 48 hips from the labral refixation and 48 hips from debridement groups with mean follow-up of 10.3±1.7 years and 10.6±2.1 years respectively were included. No significant differences were observed in the femoral head, acetabular cartilage grade, or labral grade between the groups. The mHHS improved 19.8±19.6 and 23.4±16.8 from baseline to the final follow-up in the labral refixation and debridement groups, respectively (p=0.43). There were no significant differences in PROMS between the labral refixation and debridement groups. Overall, 66% and 76% of the labral refixation and debridement groups achieved the MCID for the mHHS respectively (p=0.30). There were more revision surgeries with labral refixation than with debridement (10.4% vs. 2.1%, p=0.09), but more conversions to total hip replacement in the labral debridement group (8.3% vs. 4.2%, p=0.38), but neither of these differences were statistically significant. Discussion: Both labral refixation and debridement are effective with durable improvement in PROMS at a mean of 10 years in a prospective cohort of patients treated surgically for symptomatic FAI. No significant differences in baseline or final PROMS were observed, and similar rates of revision and conversion to hip replacement were observed in the debridement and refixation groups.
Pain during cesarean delivery: risk factors, mitigation, and current approaches
Landau, Ruth, Sharpe, Emily E.

Mayo Clinic

Current Opinion in Anaesthesiology | March 31, 2025 | Volume: 38 | Issue: 3 | Pages: 169-178

10.1097/aco.0000000000001488 | PMID 40162544 Get It

Purpose of review Pain during cesarean delivery (PDCD) has been overlooked and underreported and is associated with a traumatic birth experience and long-term morbidity. We review the studies reporting on PDCD and summarize available guidance providing roadmaps for anesthesiologists caring for patients during cesarean delivery. Recent findings PDCD is a patient-reported outcome and should not be defined by interventions mitigating insufficient neuraxial anesthesia, such as supplemental analgesic medication or general anesthesia. Depending on the cohorts studied and definitions used, current reported rates of PDCD range between 2 and 36%. Preoperative patient counseling, risk stratification, and testing of neuraxial block are mitigating strategies; ultimately, if pain occurs, it should be managed skillfully applying shared decision-making with a supportive follow-up to reduce psychological trauma. Statements from three international organizations offer guidance to prevent and treat PDCD. Summary This review provides strategies to mitigate the occurrence of PDCD, with targeted approaches to better prevent and manage PDCD.
Demographic, risk factors, and management practices of patients with acute coronary syndrome: an observational study in a tertiary care hospital in Central India
Guralwar, Chinmay , Khandait, Harshwardhan , Tekam, Prabhav, Agrawal, Antara, Mahajan, Rashi, Gawande, Nandita, Khandait, Vinod, Agrawal, Antara

Mayo Clinic

MGM Journal of Medical Sciences | March 31, 2025 | Volume: 12 | Issue: 1 | Pages: 20-26

10.4103/mgmj.mgmj_334_24 Get It

Abstract Background: Acute coronary syndrome (ACS) remains a major cause of mortality worldwide, with India reporting approximately three million cases annually. This study aims to assess the demographics, risk factors, and treatment patterns of ACS patients in Central India while exploring challenges related to pre-hospital delays and financial constraints. Materials and Methods: A cross-sectional, questionnaire-based study was conducted at a tertiary care hospital. Data from patients with ACS were collected through face-to-face interviews using a self-designed, semi-structured, open-ended questionnaire. Results: Among the 90 participants, 86.6% were diagnosed with an acute ST-segment elevation myocardial infarction (STEMI), with a male predominance (81.1%). Common risk factors included smoking, diabetes, hypertension, and a history of cardiovascular events. The primary reasons for delays in seeking medical care were a lack of recognition of symptom severity (37%), prolonged travel times (21%), and unavailability of suitable transportation (21%). Chest pain was the most frequently reported initial symptom (73.3%), with symptom onset occurring most often in the morning (43.3%). Males were more likely to experience anterior wall MI, while females predominantly presented with inferior or posterior wall MI. Emergency medical service (EMS) utilization was low, with most patients relying on personal vehicles for transportation. Additionally, rural patients required at least one additional hospital visit before reaching the tertiary care center compared to their urban counterparts. Thrombolysis was the primary treatment modality, administered to 76.67% of participants, with an average door-to-needle time of 78 ± 63 min. Conclusion: Multiple hospital referrals and inadequate EMS utilization hinder optimal ACS management. This study underscores the need for a streamlined referral process, enhanced EMS infrastructure, reduced door-to-needle time, and targeted interventions to mitigate financial barriers to ACS care in India.
EP6.75 Survivorship of first-generation FAI surgery at an average 10 year follow-up: A prospective, multicenter cohort study
Hood, Hunter, Nepple, Jeffrey J. , Thapa, Susan , Kim, Young-Jo, Sink, Ernest L. , Group, ANCHOR Study, Clohisy, John C, Sierra, Rafael J. , Beaulé, Paul E. , Group, ANCHOR Study, Clohisy, John C

Mayo Clinic

Journal of Hip Preservation Surgery | March 30, 2025 | Volume: 12 | Issue: Supplement_1 | Pages: i113-i113

10.1093/jhps/hnaf011.364 Get It

Abstract Background: Long-term outcomes of FAI surgery are critical to understand it’s hip preserving ability, yet few studies have reported mid to long-term survivorship following FAI surgery. The purpose of this study was to report rates of treatment failure after first-generation FAI surgery at an average 10- year follow-up. Methods: A prospective, multicenter cohort study assessed patients treated for FAI with hip arthroscopy or surgical dislocation by seven surgeons at four institutions from 2008 to 2012. Inclusion criteria included primary surgery and diagnosis of isolated cam or combined cam/pincer type FAI. At an average 10-year follow-up, 362/452 eligible hips (80.1%) achieved follow-up. Cox proportional hazards model was used to identify predictors of conversion to total hip arthroplasty (THA). Results: Three hundred and sixty two hips were evaluated at a mean of 10.0 ± 2.3 years follow-up. At time of final follow-up, 34 hips (9.2%) had undergone conversion to THA at a mean of 5.2 ± 3.1 years post-operatively. An additional 18 patients (4.9%) underwent non-arthroplasty revision preservation surgery at a mean of 2.0 ± 1.5 years post-operatively. The Kaplan Meier survivorship rates after 5 and 10 years of surgery were 94.9% and 95.2% for conversion to THA and 91 % and 95.2% for revision hip preservation. Older age (HR:1.06, CI: 1.01-1.10; p=0.009), BMI≥30 (HR:4.14, CI:1.52-11.24, p=0.005), male sex (HR:3.23, CI: 1.18-9.09, p=0.02), and lower baseline mHHS (HR:1.03, CI: 1.01-1.04, p=0.01) were significant predictors of conversion to THA. Conclusion: This study demonstrates that FAI surgery yields durable outcomes with the majority of patients (85.9%) not requiring revision surgery or conversion to total hip arthroplasty at an average 10 years. Age 30 years, male sex, and obesity were significantly associated with the risk of THA conversion.
Activin A Antagonism with Follistatin Reduces Kidney Fibrosis, Injury, and Cellular Senescence-Associated Inflammation in Murine Diabetic Kidney Disease
Bian, Xiaohui , Snow, Zachary K. , Zinn, C. , Gowan, Cody, Conley, Sabena M., Bratulin, Anastasia L. , Elhusseiny, Khaled , Miller, Jordan D. , Kirkland, James L. , Lerman, Lilach O. , Zinn, Caroline J, Gowan, Cody C , Elhusseiny, Khaled M , Miller, Jordan , Kirkland, James L , Lerman, Lilach O , Smith, Anastasia , Bian, Xiaohui , Tchkonia, Tamar , Hickson, LaTonya J.

Mayo Clinic

Kidney360 | March 30, 2025 | Volume: 6 | Issue: 8 | Pages: 1278-1291

10.34067/kid.0000000776 | PMID 40152935 Get It

Key Points Activin A is implicated in profibrotic and prosenescent kidney injury and correlates with kidney injury markers in animals and humans. Follistatin, through activin A antagonism, reduces senescence burden, macrophage infiltration, and proinflammatory pathway activation in murine diabetic kidney disease. Follistatin and other antagonists of activin A signaling pathways may be promising, novel therapeutics for diabetic kidney disease. Background Circulating activin A, an inflammatory mediator implicated in profibrotic kidney injury and cellular senescence-induced adipose tissue dysfunction, is increased in human diabetic kidney disease (DKD) and directly correlates with kidney dysfunction. We tested the hypothesis that activin A increases kidney injury, senescent cell abundance, and macrophage infiltration in DKD and antagonism through follistatin (FS) therapy diminishes these effects. Methods An accelerated nephropathy type 2 diabetes (db/db) mouse model was generated by implantation of angiotensin II-loaded osmotic minipumps resulting in increased albuminuria and glomerular and tubular injury. Kidney repair effects of FS (5 µ g intraperitoneal; two doses) were assessed through markers of kidney injury, fibrosis, inflammation, cellular senescence, and macrophage infiltration. In vitro studies examined antiactivin effects of FS on high glucose-exposed human monocytes, renal fibroblasts, and renal tubule epithelial cells. Results Activin A antagonism with FS reduced senescence (p19), proinflammatory (including senescence-associated secretory phenotype), and profibrotic markers including activin A. FS improved kidney morphology, restored podocyte markers (nephrin and Wilms tumor-1), and reduced kidney injury biomarkers, albuminuria and kidney fibrosis. FS decreased kidney macrophage and leukocyte infiltration and absent in melanoma 2 inflammasome activation. FS seemed to suppress inflammation through the toll-like receptor-4/NF kappa-light-chain-enhancer of activated B cells pathway in vivo further supported in human macrophages in vitro . In addition, FS reduced hyperglycemia-induced renal fibroblast activation and renal tubule epithelial cell senescence in vitro . Conclusions Activin A is a mediator of kidney injury through macrophage-associated inflammation in murine DKD. FS acts through senomorphic activities which inhibit profibrotic, proinflammatory, and prosenescence signaling by activin A. Hence, antiactivin targeting may aid in the development of a promising, novel therapeutic for DKD.
Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-regurgitation study
Long, Aaron S. , Finer, Joshua , Hartzel, Dustin N. , Jing, Linyuan, Ruhl, Jeffrey , vanMaanen, David P., Elnabawi, Youssef , Metser, Gil , Duffy, Eamon , Mawson, Thomas, Tat, Emily , Kumaraiah, Deepa, Devereux, Richard B., Homma, Shunichi, Leon, Martin B. , Hahn, Rebecca T , Poterucha, Timothy J. , Ruhl, Jeffrey , Hahn, Rebecca T , Elias, Pierre , Poterucha, Timothy Joseph , Long, Aaron, Hartman, Heidi S. , Jing, Linyuan , Kelsey, Chris R. , Rocha, Daniel , Haggerty, Christopher M. , Maurer, Matthew J. , Einstein, Andrew Jeffrey , Beecy, Ashley , Devereux, Richard B.

Mayo Clinic

European Heart Journal | March 29, 2025 | Volume: 46 | Issue: 28 | Pages: 2780-2791

10.1093/eurheartj/ehaf248 | PMID 40156921 Get It

Abstract Background and Aims Classification and risk stratification in aortic (AR), mitral (MR), and tricuspid regurgitation (TR) remains a significant clinical challenge. This study aimed to develop an artificial intelligence (AI) system to assess valvular regurgitation and stratify MR-progression risk. Methods Using transthoracic echocardiograms (TTEs) at two sites (internal development/test, external test), the DELINEATE-Regurgitation system was developed to classify AR, MR, and TR severity using colour Doppler videos. Methods of summating video-level classifications into study-level predictions were tested, comparing single-view with multiview approaches integrating predictions across multiple videos. Model agreement with cardiologists was assessed by weighted kappa. A separate AI system (DELINEATE-MR-Progression) analysing colour Doppler videos was developed to predict which patients with mild, mild–moderate, and moderate MR were most likely to progress to moderate–severe or severe MR with analysis by Kaplan–Meier and Cox proportional hazards models. Results A total of 71 660 TTEs with 1 203 980 colour Doppler videos were included. The weighted kappa in internal/external test sets for regurgitation classification was 0.81/0.76 for AR, 0.76/0.72 for MR, and 0.73/0.64 for TR using a multiview approach taking all colour Doppler videos in a study, demonstrating substantial agreement with cardiologist interpretation with superiority of multiview over single view approaches. In the progression analysis, the AI score stratified MR-progression risk even when controlled for clinical factors known to be associated with MR progression [internal test set hazard ratio 4.1 (95% confidence interval 2.5–6.6)]. Conclusions An AI system can accurately classify AR, MR, and TR and predict MR progression beyond currently known risk factors.
Digital transformation of nephrology POCUS education—Integrating a multiagent, artificial intelligence, and human collaboration-enhanced curriculum with expert feedback
Sheikh, M. Salman , Kashani, Kianoush , Gregoire, James R., Thongprayoon, Charat , Miao, Jing , Craici, Iasmina , Cheungpasitporn, Wisit , Qureshi, Fawad , Sheikh, Mohammad S , Kashani, Kianoush B , Craici, Iasmina M, Qureshi, Fawad , Cheungpasitporn, Wisit , Thongprayoon, Charat , Miao, Jing

Mayo Clinic

DIGITAL HEALTH | March 28, 2025 | Volume: 11 | Issue: No issue available | Pages: No page available

10.1177/20552076251328807 | PMID 40162173 Get It

Background The digital transformation in medical education is reshaping how clinical skills, such as point-of-care ultrasound (POCUS), are taught. In nephrology fellowship programs, POCUS is essential for enhancing diagnostic accuracy, guiding procedures, and optimizing patient management. To address these evolving demands, we developed an artificial intelligence (AI)-driven POCUS curriculum using a multiagent approach that integrates human expertise with advanced AI models, thereby elevating educational standards and better preparing fellows for contemporary clinical practice. Methods In April 2024, the Mayo Clinic Minnesota Nephrology Fellowship Program initiated a novel AI-assisted process to design a comprehensive POCUS curriculum. This process integrated multiple advanced AI models—including GPT-4.0, Claude 3.0 Opus, Gemini Advanced, and Meta AI with Llama 3—to generate initial drafts and iteratively refine content. A panel of blinded nephrology POCUS experts subsequently reviewed and modified the AI-generated material to ensure both clinical relevance and educational rigor. Results The curriculum underwent 12 iterative revisions, incorporating feedback from 29 communications across AI models. Key features of the final curriculum included expanded core topics, diversified teaching methods, enhanced assessment tools, and integration into inpatient and outpatient nephrology rotations. The curriculum emphasized quality assurance, POCUS limitations, and essential clinical applications, such as fistula/graft evaluation and software integration. Alignment with certification standards further strengthened its utility. AI models contributed significantly to the curriculum's foundational structure, while human experts provided critical clinical insights. Conclusion This curriculum, enhanced through a multiagent approach that combines AI and human collaboration, exemplifies the transformative potential of digital tools in nephrology education. The innovative framework seamlessly integrates advanced AI models with expert clinical insights, providing a scalable model for medical curriculum development that is responsive to evolving educational demands. The synergy between technological innovation and human expertise holds promising implications for advancing fellowship training. Future studies should evaluate its impact on clinical competencies and patient outcomes across diverse practice environments.
HSR25-141: Adolescent and Young Adult Cancer Patients: Our Most Financially Vulnerable Demographic
Lee, Minji K. , Steinert, Kimberly O., Mason, Jordan A., Hanson, Wendy A., Kimball, Brittany , Mason, Jordan A., Hanson, Wendy A., Allen‐Rhoades, Wendy , Rosenthal, Allison , McWilliams, Robert R.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 28, 2025 | Volume: 23 | Issue: 3.5 | Pages: No page available

10.6004/jnccn.2024.7287 Get It

CLO25-087: Low Serum Pseudocholinesterase Level Predicts HCC Mortality As Accurately As the ALBI or MESIAH Score
Espinoza, Angela Karina Sato, Chotiprasidhi, Perapa , Larson, Joseph J. , Wangensteen, Kirk J. , Wangensteen, Kirk J , Espinoza, Angela Karina Sato, Roberts, Lewis R.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 28, 2025 | Volume: 23 | Issue: 3.5 | Pages: No page available

10.6004/jnccn.2024.7177 Get It